Frontiers in Psychiatry,
Journal Year:
2024,
Volume and Issue:
15
Published: May 8, 2024
Drugs
targeting
monoamine
systems
remain
the
most
common
treatment
for
disorders
with
impulse
control
impairments.
There
is
a
body
of
literature
suggesting
that
drugs
affecting
serotonin
reuptake
and
dopamine
can
modulate
distinct
aspects
impulsivity
-
though
such
tests
are
often
performed
using
behavioral
tasks
prohibiting
easy
comparisons.
Here,
we
directly
compare
pharmacologic
agents
affect
(methylphenidate)
vs
(citalopram)
manipulations
on
choice
in
temporal
discounting
task
where
rats
could
choose
between
small,
immediate
reward
or
large
delayed
at
either
2
10s.
In
conditions,
preferred
small
(2s)
delay
discounted
long
(10s)
delay.
Methylphenidate,
transport
inhibitor
blocks
dopamine,
dose-dependently
increased
preference
block.
Citalopram,
selective
inhibitor,
had
no
effect
behavior.
Impulsive
behavior
was
least
partially
mediated
by
nucleus
accumbens
shell.
Bilateral
lesions
to
shell
reduced
during
Following
lesions,
methylphenidate
did
not
impact
impulsivity.
Our
results
suggest
striatal
dopaminergic
via
actions
within
shell,
whereas
may
regulate
different
inhibition/impulsivity.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
Abstract
Importance
To
support
treatment
assignment,
mechanistic
biomarkers
should
be
selectively
sensitive
to
specific
interventions.
Here,
we
examine
whether
different
components
of
reinforcement
learning
in
humans
satisfy
this
necessary
precondition.
We
focus
on
pharmacological
manipulations
dopamine
and
serotonin
that
form
the
backbone
first-line
management
common
mental
illnesses
such
as
depression
anxiety.
Objective
perform
a
meta-analysis
they
show
distinct
associations
with
humans.
Data
Sources
Ovid
MEDLINE/PubMed,
Embase,
PsycInfo
databases
were
searched
for
studies
published
between
January
1,
1946
19,
2023
(repeated
April
9,
2024,
October
15,
2024)
investigating
dopaminergic
or
serotonergic
effects
reward/punishment
processes
humans,
according
PRISMA
guidelines.
Study
Selection
Studies
reporting
randomized,
placebo-controlled,
behavioral
outcome
from
processing
task
healthy
included.
Extraction
Synthesis
Standardized
mean
difference
(SMD)
scores
calculated
comparison
each
drug
(dopamine/serotonin)
placebo
reward
punishment
quantified
random-effects
models
overall
four
main
subcategories.
quality
(Cochrane
Collaboration’s
tool),
moderators,
heterogeneity,
publication
bias
also
assessed.
Main
Outcome(s)
Measure(s)
Performance
tasks.
Results
In
total,
68
39
volunteers
included
(N
=2291,
N
=2284;
=1491,
=1523).
Dopamine
was
associated
an
increase
(SMD=0.18,
95%CI
[0.09
0.28])
but
not
function
(SMD=-0.06,
[−0.26,0.13]).
Serotonin
meaningfully
(SMD=0.22,
[−0.04,0.49])
(SMD=0.02,
[−0.33,0.36]).
Importantly,
had
subcomponents.
learning/sensitivity
(SMD=0.26,
[0.11,0.40]),
discounting
(SMD=-0.08,
[−0.14,-0.01])
vigor
(SMD=0.32,
[0.11,0.54]).
By
contrast,
[0.05,0.59]),
(SMD=-0.35,
[−0.67,-0.02]),
aversive
Pavlovian
(within-subject
only;
SMD=0.36,
[0.20,0.53]).
Conclusions
Relevance
Pharmacological
both
have
measurable
The
selective
suggests
tasks
could
basis
selective,
mechanistically
interpretable
assignment.
Key
points
Question
Do
affect
humans?
Findings
Upregulating
is
increased
response
vigor,
decreased
discounting.
Upregulation
Meaning
dissociable
learning.
This
forms
development
markers
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(7), P. 847 - 847
Published: June 22, 2024
Despite
the
prevalence
of
depression
in
lactating
mothers,
there
is
a
lack
knowledge
about
excretion
antidepressants
into
breast
milk
and
its
potential
adverse
effects
on
infants.
This
creates
concern,
making
depressed
mothers
more
likely
to
avoid
pharmacological
treatment.
Clinical
lactation
studies
are
most
accurate
direct
method
predict
demonstrate
human
milk,
results
from
clinical
can
be
included
drug
labels
help
physicians
patients
make
decisions
antidepressant
use
during
lactation.
However,
limited
trials
pharmacokinetics
women
because
enrollment
ethical
confounding
factors,
creating
this
area.
To
bridge
gap
knowledge,
alternative
methods
should
sought
estimate
concentration
which
used
assess
safety
transfer
milk.
We
provide
comprehensive
review
usage
these
cost-effective,
time-efficient,
ethically
feasible
that
serve
valuable
estimation
before
conducting
studies.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(17), P. 9427 - 9427
Published: Aug. 30, 2024
Obstructive
Sleep
Apnea
(OSA)
is
a
disorder
characterized
by
repeated
upper
airway
collapse
during
sleep,
leading
to
apneas
and/or
hypopneas,
with
associated
symptoms
like
intermittent
hypoxia
and
sleep
fragmentation.
One
of
the
agents
contributing
OSA
occurrence
development
seems
be
serotonin
(5-HT).
Currently,
research
focuses
on
establishing
interlinking
pathogenesis
severity
disease
molecular
neurotransmitter
omnipresent
in
human
body—serotonin,
its
pathway,
products,
receptors,
drugs
affecting
levels
serotonin,
or
genetic
predisposition.
The
5-HT
system
numerous
physiological
processes
such
as
digestion,
circulation,
respiration,
muscle
tone—all
which
are
considered
factors
promoting
influencing
course
because
correlations
comorbid
conditions.
Comorbidities
include
obesity,
behavioral
disorders
well
cardiovascular
diseases.
Additionally,
both
imbalance
connected
psychiatric
comorbidities,
depression,
anxiety,
cognitive
dysfunction.
Pharmacological
that
target
receptors
have
shown
varying
degrees
efficacy
reducing
Apnea-Hypopnea
Index
improving
symptoms.
potential
role
signaling
pathway
modulating
provides
promising
avenue
for
new
therapeutic
interventions
could
accompany
primary
treatment
OSA—continuous
positive
pressure.
Thus,
this
review
aims
elucidate
complex
regulatory
mechanisms
pathophysiology,
evaluating
target.
We
also
summarize
relationship
between
various
functions,
Memory
and
emotion
are
highly
vulnerable
to
psychiatric
disorders
like
post-traumatic
stress
disorder
(PTSD),
which
has
been
linked
serotonin
(5-HT)
metabolism
disruptions.
In
fact,
over
90%
of
the
5-HT
precursor
tryptophan
(Trp)
is
metabolized
via
Trp-kynurenine
(KYN)
meta-bolic
pathway,
producing
a
variety
bioactive
molecules.
The
aadat
(kat2)
gene
encodes
mito-chondrial
kynurenine
aminotransferase
(KAT)
isotype
2,
responsible
for
kynurenic
acid
(KYNA)
production.
Little
known
about
its
role
in
behavior.
CRISPR/Cas9-induced
knockout
(kat2−/−)
mice,
we
examined
effects
on
emotion,
memory,
motor
function,
Trp
metabolite
levels,
enzyme
activities
plasma
urine
8-week-old
males
compared
wild-type
mice.
Transgenic
mice
showed
more
depressive-like
behaviors
forced
swim
test,
but
not
tail
suspension,
anxiety,
or
memory
tests.
They
also
had
fewer
center
field
corner
entries,
shorter
walking
distances,
jumping
counts
open
test.
Plasma
levels
generally
consistent
with
those
urine:
KYN,
antioxidant
KYNs,
5-hydroxyindolacetic
acid,
indole-3-acetic
lower;
KATs,
kynureninase,
monoamine
oxidase/aldehyde
dehydrogenase
lower,
3-monooxygenase
higher;
ox-idative
excitotoxicity
indices
higher.
show
depression-like
behavior
learned
helplessness
model,
emotional
indifference,
deficits,
coupled
decrease
KYNA,
shift
toward
KYN-3-HK
partial
gut
microbial
Trp-indole
pathway
metabolite.
This
first
evidence
that
deleting
causes
unique
despair
experience,
appears
be
excitatory
neurotoxic
oxidative
stresses.
may
lead
development
double-hit
preclinical
model
experience-based
depression,
better
understanding
these
complex
condi-tions,
effective
therapeutic
strategies
by
elucidating
relationship
between
me-tabolism
PTSD
pathogenesis.
Frontiers in Psychiatry,
Journal Year:
2024,
Volume and Issue:
15
Published: May 8, 2024
Drugs
targeting
monoamine
systems
remain
the
most
common
treatment
for
disorders
with
impulse
control
impairments.
There
is
a
body
of
literature
suggesting
that
drugs
affecting
serotonin
reuptake
and
dopamine
can
modulate
distinct
aspects
impulsivity
-
though
such
tests
are
often
performed
using
behavioral
tasks
prohibiting
easy
comparisons.
Here,
we
directly
compare
pharmacologic
agents
affect
(methylphenidate)
vs
(citalopram)
manipulations
on
choice
in
temporal
discounting
task
where
rats
could
choose
between
small,
immediate
reward
or
large
delayed
at
either
2
10s.
In
conditions,
preferred
small
(2s)
delay
discounted
long
(10s)
delay.
Methylphenidate,
transport
inhibitor
blocks
dopamine,
dose-dependently
increased
preference
block.
Citalopram,
selective
inhibitor,
had
no
effect
behavior.
Impulsive
behavior
was
least
partially
mediated
by
nucleus
accumbens
shell.
Bilateral
lesions
to
shell
reduced
during
Following
lesions,
methylphenidate
did
not
impact
impulsivity.
Our
results
suggest
striatal
dopaminergic
via
actions
within
shell,
whereas
may
regulate
different
inhibition/impulsivity.